Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Escherichia coli F5 fimbrial adhesin, historically known as the K99 antigen, is a filamentous surface appendage found on enterotoxigenic E. coli (ETEC) strains that primarily infect neonatal calves, lambs, and piglets (UniProt: P02971). It is a critical virulence factor that facilitates the colonization of the small intestine by binding to specific sialic acid-containing glycoconjugates, such as N-glycolylneuraminic acid (Neu5Gc)-GM3, on the host's epithelial cells (PubMed: 3025437). This attachment is the essential first step for the bacteria to colonize the gut and subsequently release enterotoxins that cause severe secretory diarrhea, a condition known as colibacillosis (Merck Veterinary Manual). Because of its vital role in pathogenesis, the F5 adhesin is a primary target for veterinary immunoprophylaxis. Therapeutic strategies include maternal vaccination to enhance the transfer of specific antibodies through colostrum and the oral administration of monoclonal antibodies to newborn animals to provide immediate passive immunity (PubMed: 1643504). These interventions effectively prevent bacterial docking and the subsequent onset of clinical disease.
Neutralization of the F5 fimbrial adhesin to prevent bacterial attachment to the intestinal mucosa, thereby inhibiting colonization and the subsequent effects of enterotoxins (PubMed: 1643504).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli F5 fimbrial adhesin (F5).